Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib with Chemoradiotherapy in Stage III NSCLC
NCT02412371Phase 2Terminated
- Sponsor
- AbbVie Inc.
- Start
- Apr 2015
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of veliparib in non-small cell lung cancer (NSCLC), sponsored by AbbVie Inc.. Started Apr 2015; status: terminated.
02
Drugs
veliparib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02412371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02412371.